| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.4 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.13 | 0.4 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.5 |